Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?

Author： Smith Julian C.   Tarocco Giorgio   Merazzi Fabio   Salzmann Urs  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.4, 2006-04, pp. : 709-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane

By Taylor Peter W.   Keenan Michael H. J.  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 603-615

Informa Healthcare

Access to resources Recommend Favorite

In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada

By Walker A.D.   Adachi J.D.  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1749-1754

Informa Healthcare

Access to resources Recommend Favorite

Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK

By Guest Julian F.   Clegg John P.   Smith Andrew F.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

The art of prescribing: negotiating the decision of generic or branded medications

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 7, 2015-07 ,pp. : 774-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. : 508-517

John Wiley & Sons Inc

Access to resources Recommend Favorite